Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 94
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 87
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,382 Results (Page 16 of 120)
- Relevance
  Sort by

Antibacterial Drugs Market 2024-2028

 Report
July 2024
189 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Antibody Drug Conjugate (ADC) Technology Market Industry Trends and Global Forecasts to 2035, by Generation of Technology, Type of Conjugation, Type of Linker, Type of Payment Model Adopted and Key Geographical Regions

 Report
March 2025
407 Pages
Global

From

€4186EUR$4,799USD£3,646GBP

Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1308EUR$1,500USD£1,140GBP

Antimicrobial Therapeutics Market 2024-2028

 Report
June 2024
175 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
138 Pages
Global

From

€1745EUR$2,000USD£1,519GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pharmaceutical Drug Delivery Market by Route of Administration, by Application, Regional Outlook - Global Forecast up to 2030

 Report
July 2024
120 Pages
Global

From

€3925EUR$4,500USD£3,419GBP

Coronary Artery Disease Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
129 Pages
Global

From

€4143EUR$4,750USD£3,609GBP

Clobetasol Propionate API Market - Global Forecast to 2030

 Report
August 2025
182 Pages
Global

From

€3436EUR$3,939USD£2,992GBP

Hepatitis B Virus Infection - Global Drug Forecast and Market Analysis to 2029

 Report
March 2021
132 Pages
Global

From

€13080EUR$14,995USD£11,391GBP

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
2271 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Paracetamol IV - Global Strategic Business Report

 Report
February 2026
374 Pages
Global

From

€5103EUR$5,850USD£4,444GBP

Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
185 Pages
Global

€4357EUR$4,995USD£3,795GBP

Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
90 Pages
Africa, Middle East

From

€4143EUR$4,750USD£3,609GBP

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
574 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Immunosuppressants Market 2024-2028

 Report
July 2024
138 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Vascular Endothelial Growth Factor (Vegf) Inhibitors Market 2024-2028

 Report
May 2024
178 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Sickle Cell Disease Treatment - Global Strategic Business Report

 Report
February 2026
182 Pages
Global

From

€5103EUR$5,850USD£4,444GBP

Antithrombotic Drugs Market - Global Strategic Business Report

 Report
February 2026
282 Pages
Global

From

€5103EUR$5,850USD£4,444GBP

Sickle-Cell Anemia Therapeutics - Global Strategic Business Report

 Report
February 2026
181 Pages
Global

From

€5103EUR$5,850USD£4,444GBP

Hematological Malignancies - Global Strategic Business Report

 Report
February 2026
193 Pages
Global

From

€5103EUR$5,850USD£4,444GBP

2,382 Results (Page 16 of 120)
- 1
- 14
- 15
- 16
- 17
- 18

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.